Literature DB >> 18607783

The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration.

Radbod Darabi1, Filipe N C Santos, Rita C R Perlingeiro.   

Abstract

Muscular dystrophy (MD) refers to a group of more than 30 genetically and clinically heterogeneous disorders, characterized by progressive weakness and degeneration of the skeletal muscles that control movement. To date, MD is still incurable but increasing evidence suggests that stem cells might represent a therapeutic option in the future. This review will outline recent progress in this field involving the use of adult and embryonic stem cells. We will discuss in further detail the nature of these cells and their distinct biological properties which lead to their unique advantages and disadvantages in regard to therapeutic application.

Entities:  

Mesh：

Year:  2008        PMID： 18607783     DOI： 10.1007/s12015-008-9023-3

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN： 1550-8943            Impact factor:   5.739


  121 in total

1.  Viable offspring derived from fetal and adult mammalian cells.

Authors:  I Wilmut; A E Schnieke; J McWhir; A J Kind; K H Campbell
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

2.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

Authors:  M A Goodell; M Rosenzweig; H Kim; D F Marks; M DeMaria; G Paradis; S A Grupp; C A Sieff; R C Mulligan; R P Johnson
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

3.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  Direct isolation of satellite cells for skeletal muscle regeneration.

Authors:  Didier Montarras; Jennifer Morgan; Charlotte Collins; Frédéric Relaix; Stéphane Zaffran; Ana Cumano; Terence Partridge; Margaret Buckingham
Journal:  Science       Date:  2005-09-01       Impact factor: 47.728

5.  A cat cloned by nuclear transplantation.

Authors:  T Shin; D Kraemer; J Pryor; L Liu; J Rugila; L Howe; S Buck; K Murphy; L Lyons; M Westhusin
Journal:  Nature       Date:  2002-02-14       Impact factor: 49.962

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  Embryonic stem cells can form germ cells in vitro.

Authors:  Yayoi Toyooka; Naoki Tsunekawa; Ryuko Akasu; Toshiaki Noce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice.

Authors:  So-ichiro Fukada; Yuko Miyagoe-Suzuki; Hiroshi Tsukihara; Katsutoshi Yuasa; Saito Higuchi; Shiro Ono; Kazutake Tsujikawa; Shin'ichi Takeda; Hiroshi Yamamoto
Journal:  J Cell Sci       Date:  2002-03-15       Impact factor: 5.285

10.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

Authors:  Arianna Dellavalle; Maurilio Sampaolesi; Rossana Tonlorenzi; Enrico Tagliafico; Benedetto Sacchetti; Laura Perani; Anna Innocenzi; Beatriz G Galvez; Graziella Messina; Roberta Morosetti; Sheng Li; Marzia Belicchi; Giuseppe Peretti; Jeffrey S Chamberlain; Woodring E Wright; Yvan Torrente; Stefano Ferrari; Paolo Bianco; Giulio Cossu
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824
View more
  11 in total

1.  Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.

Authors:  Jérome Chal; Ziad Al Tanoury; Marie Hestin; Bénédicte Gobert; Suvi Aivio; Aurore Hick; Thomas Cherrier; Alexander P Nesmith; Kevin K Parker; Olivier Pourquié
Journal:  Nat Protoc       Date:  2016-09-01       Impact factor: 13.491

2.  Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin.

Authors:  Amanda A Steffens; Gia-Ming Hong; Lisa J Bain
Journal:  Toxicol Appl Pharmacol       Date:  2010-10-18       Impact factor: 4.219

Review 3.  Emerging genetic therapies to treat Duchenne muscular dystrophy.

Authors:  Stanley F Nelson; Rachelle H Crosbie; M Carrie Miceli; Melissa J Spencer
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

4.  Sdf-1 (CXCL12) induces CD9 expression in stem cells engaged in muscle regeneration.

Authors:  Edyta Brzoska; Kamil Kowalski; Agnieszka Markowska-Zagrajek; Magdalena Kowalewska; Rafał Archacki; Izabela Plaskota; Władysława Stremińska; Katarzyna Jańczyk-Ilach; Maria A Ciemerych
Journal:  Stem Cell Res Ther       Date:  2015-03-24       Impact factor: 6.832

5.  Evaluating Electroporation and Lipofectamine Approaches for Transient and Stable Transgene Expressions in Human Fibroblasts and Embryonic Stem Cells.

Authors:  Mehdi Sharifi Tabar; Mahdi Hesaraki; Fereshteh Esfandiari; Fazel Sahraneshin Samani; Haghighat Vakilian; Hossein Baharvand
Journal:  Cell J       Date:  2015-10-07       Impact factor: 2.479

Review 6.  Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.

Authors:  Yuji Ogura; Marjan M Tajrishi; Shuichi Sato; Sajedah M Hindi; Ashok Kumar
Journal:  Front Cell Dev Biol       Date:  2014-04-01

7.  Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.

Authors:  Sajedah M Hindi; Jonghyun Shin; Yuji Ogura; Hong Li; Ashok Kumar
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

Review 8.  Advancements in stem cells treatment of skeletal muscle wasting.

Authors:  Mirella Meregalli; Andrea Farini; Clementina Sitzia; Yvan Torrente
Journal:  Front Physiol       Date:  2014-02-12       Impact factor: 4.566

Review 9.  The immune boundaries for stem cell based therapies: problems and prospective solutions.

Authors:  Abdelkrim Hmadcha; Hmadcha Abdelkrim; Juan Domínguez-Bendala; Domínguez-Bendala Juan; Jane Wakeman; Wakeman Jane; Mohamed Arredouani; Arredouani Mohamed; Bernat Soria; Soria Bernat
Journal:  J Cell Mol Med       Date:  2009-07-06       Impact factor: 5.310

10.  Myogenic Differentiation of Mouse Embryonic Stem Cells That Lack a Functional Pax7 Gene.

Authors:  Areta M Czerwinska; Iwona Grabowska; Karolina Archacka; Joanna Bem; Barbara Swierczek; Anita Helinska; Wladyslawa Streminska; Anna Fogtman; Roksana Iwanicka-Nowicka; Marta Koblowska; Maria A Ciemerych
Journal:  Stem Cells Dev       Date:  2016-01-19       Impact factor: 3.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.